Lung Cancer Volume 2: Diagnostic and Therapeutic Methods and Reviews /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2003.
|
| Edición: | 1st ed. 2003. |
| Colección: | Methods in Molecular Medicine,
75 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1385/1592593240 |
Tabla de Contenidos:
- Molecular and Genetic Aspects of Lung Cancer
- Detection of Altered Tumor Markers in Clinical Samples for Diagnosis and Prognosis
- Molecular Alterations in Lung Cancer
- Cellular Predictive Factors of Drug Resistance in Non-Small Cell Lung Carcinomas
- Clinical Implications of p53 Mutations in Lung Cancer
- An Epidemiologic and Clinicopathologic Overview of AIDS-Associated Pulmonary Kaposi’s Sarcoma
- Myeloperoxidase Promoter Region Polymorphism and Lung Cancer Risk
- Clinical Utility of Tumor Markers in the Management of Non-Small Cell Lung Cancer
- Detection of Chromosomal Aberrations in Lung Tissue and Peripheral Blood Lymphocytes Using Interphase Fluorescence In Situ Hybridization (FISH)
- In Situ Analysis of Telomerase RNA Gene Expression as a Marker for Tumor Progression
- A High-Throughput Methodology for Identifying Molecular Targets Overexpressed in Lung Cancers
- Expression Profiling of Lung Cancer Based on Suppression Subtraction Hybridization (SSH)
- Comparative Genomic Hybridization of Human Lung Cancer
- Sensitive Assays for Detection of Lung Cancer
- Fluorescent Microsatellite Analysis in Bronchial Lavage as a Potential Diagnostic Tool for Lung Cancer
- Southern Blotting of Genomic DNA from Lung and Its Tumors
- Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity as Predictors of Lung Cancer Risk
- Comparative Multiplex PCR and Allele-Specific Expression Analysis in Human Lung Cancer
- Detection of K-ras Point Mutations in Sputum from Patients with Adenocarcinoma of the Lung by Point-EXACCT
- Detection of K-ras and p53 Mutations by “Mutant-Enriched” PCR-RFLP
- Detection of Small Cell Lung Cancer by RT-PCR for Neuropeptides, Neuropeptide Receptors, or a Splice Variant of the Neuron Restrictive Silencer Factor
- Utilization of Thyroid Transcription Factor-1 Immunostaining in the Diagnosis of Lung Tumors
- Molecular Biologic Substaging of Stage I NSCLC Through Immunohistochemistry Performed on Formalin-Fixed, Paraffin-Embedded Tissue
- A Sensitive Immunofluorescence Assay for Detection of p53 Protein in the Sputum
- SPR1
- Determination of Biological Parameters on Fine-Needle Aspirates from Non-Small Cell Lung Cancer
- Detection and Analysis of Lung Cancer Cells from Body Fluids Using a Rare Event Imaging System
- Reconstruction of Geno-Phenotypic Evolutionary Sequences from Intracellular Patterns of Molecular Abnormalities in Human Solid Tumors
- Novel Therapies
- Surgical Treatment of Lung Cancer
- Recent Advances and Dilemmas in the Radiotherapeutic Management of Locally Advanced Non-Small Cell Lung Cancer
- Photodynamic Therapy in Lung Cancer
- Gene Therapy for Lung Cancer
- Identifying Obstacles to Viral Gene Therapy for Lung Cancer
- Topical Gene Therapy for Pulmonary Diseases with PEI-DNA Aerosol Complexes
- Targeted Delivery of Expression Plasmids to the Lung via Macroaggregated Polyethylenimine-Albumin Conjugates
- Preparation of Retroviral Vectors for Cell-Cycle-Targeted Gene Therapy of Lung Cancer
- Aerosol Gene Therapy for Metastatic Lung Cancer Using PEI-p53 Complexes
- Clinical Development of Antisense Oligonucleotides as Anti-Cancer Therapeutics
- Antisense Oligonucleotides Targeting RI? Subunit of Protein Kinase A
- Use of Antisense Oligonucleotides for Therapy
- Induction of Programmed Cell Death with an Antisense Bcl-2 Oligonucleotide
- Tumor Vaccination with Cytokine-Encapsulated Microspheres
- Adoptive Immunotherapy
- Intratumoral Therapy with Cytokine Gene-Modified Dendritic Cells in Murine Lung Cancer Models
- Cyclooxygenase 2-Dependent Regulation of Antitumor Immunity in Lung Cancer
- Chemoprevention of Lung Cancer
- Assessing the Interaction of Particulate Delivery Systems with Lung Surfactant
- Chemopreventive Therapeutics.